Literature DB >> 33560471

Serotonin-specific neurons differentiated from human iPSCs form distinct subtypes with synaptic protein assembly.

Charline Jansch1, Georg C Ziegler2,3, Andrea Forero1, Sina Gredy4,5, Sina Wäldchen6, Maria Rosaria Vitale1,5, Evgeniy Svirin1,5, Johanna E M Zöller1,7, Jonas Waider1, Katharina Günther8,9, Frank Edenhofer8, Markus Sauer6, Erhard Wischmeyer1,4, Klaus-Peter Lesch10,11,12.   

Abstract

Human induced pluripotent stem cells (hiPSCs) have revolutionized the generation of experimental disease models, but the development of protocols for the differentiation of functionally active neuronal subtypes with defined specification is still in its infancy. While dysfunction of the brain serotonin (5-HT) system has been implicated in the etiology of various neuropsychiatric disorders, investigation of functional human 5-HT specific neurons in vitro has been restricted by technical limitations. We describe an efficient generation of functionally active neurons from hiPSCs displaying 5-HT specification by modification of a previously reported protocol. Furthermore, 5-HT specific neurons were characterized using high-end fluorescence imaging including super-resolution microscopy in combination with electrophysiological techniques. Differentiated hiPSCs synthesize 5-HT, express specific markers, such as tryptophan hydroxylase 2 and 5-HT transporter, and exhibit an electrophysiological signature characteristic of serotonergic neurons, with spontaneous rhythmic activities, broad action potentials and large afterhyperpolarization potentials. 5-HT specific neurons form synapses reflected by the expression of pre- and postsynaptic proteins, such as Bassoon and Homer. The distribution pattern of Bassoon, a marker of the active zone along the soma and extensions of neurons, indicates functionality via volume transmission. Among the high percentage of 5-HT specific neurons (~ 42%), a subpopulation of CDH13 + cells presumably designates dorsal raphe neurons. hiPSC-derived 5-HT specific neuronal cell cultures reflect the heterogeneous nature of dorsal and median raphe nuclei and may facilitate examining the association of serotonergic neuron subpopulations with neuropsychiatric disorders.

Entities:  

Keywords:  Cadherin-13 (CDH13); Human induced pluripotent stem cell (hiPSC); Median and dorsal raphe; Neuropsychiatric disorders; Serotonin-specific neurons; Synapse formation

Year:  2021        PMID: 33560471      PMCID: PMC7914246          DOI: 10.1007/s00702-021-02303-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  96 in total

Review 1.  Nonsynaptic communication in the central nervous system.

Authors:  E Sylvester Vizi; Janos P Kiss; Balazs Lendvai
Journal:  Neurochem Int       Date:  2004-09       Impact factor: 3.921

2.  Generation of functional human serotonergic neurons from fibroblasts.

Authors:  K C Vadodaria; J Mertens; A Paquola; C Bardy; X Li; R Jappelli; L Fung; M C Marchetto; M Hamm; M Gorris; P Koch; F H Gage
Journal:  Mol Psychiatry       Date:  2015-10-27       Impact factor: 15.992

Review 3.  Synaptic and extrasynaptic secretion of serotonin.

Authors:  Francisco F De-Miguel; Citlali Trueta
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

4.  Median and Dorsal Raphe Serotonergic Neurons Control Moderate Versus Compulsive Cocaine Intake.

Authors:  Michel M M Verheij; Candice Contet; Peter Karel; Judith Latour; Rick H A van der Doelen; Bram Geenen; Josephus A van Hulten; Francisca Meyer; Tamas Kozicz; Olivier George; George F Koob; Judith R Homberg
Journal:  Biol Psychiatry       Date:  2017-11-20       Impact factor: 13.382

5.  Inhibition of motor axon growth by T-cadherin substrata.

Authors:  B J Fredette; J Miller; B Ranscht
Journal:  Development       Date:  1996-10       Impact factor: 6.868

6.  SLC52A3, A Brown-Vialetto-van Laere syndrome candidate gene is essential for mouse development, but dispensable for motor neuron differentiation.

Authors:  Atsushi Intoh; Naoki Suzuki; Kathryn Koszka; Kevin Eggan
Journal:  Hum Mol Genet       Date:  2016-03-13       Impact factor: 6.150

Review 7.  Serotonin-dopamine interaction and its relevance to schizophrenia.

Authors:  S Kapur; G Remington
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

8.  Genome-wide association for methamphetamine dependence: convergent results from 2 samples.

Authors:  George R Uhl; Tomas Drgon; Qing-Rong Liu; Catherine Johnson; Donna Walther; Tokutaro Komiyama; Mutsuo Harano; Yoshimoto Sekine; Toshiya Inada; Norio Ozaki; Masaomi Iyo; Nakao Iwata; Mitsuhiko Yamada; Ichiro Sora; Chih-Ken Chen; Hsing-Cheng Liu; Hiroshi Ujike; Shih-Ku Lin
Journal:  Arch Gen Psychiatry       Date:  2008-03

9.  Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline.

Authors:  Jennifer I Lissemore; Debbie Sookman; Paul Gravel; Alexandre Berney; Amir Barsoum; Mirko Diksic; Thomas E Nordahl; Gilbert Pinard; Igor Sibon; Jean Cottraux; Marco Leyton; Chawki Benkelfat
Journal:  Transl Psychiatry       Date:  2018-04-18       Impact factor: 6.222

10.  Cadherin-13 Deficiency Increases Dorsal Raphe 5-HT Neuron Density and Prefrontal Cortex Innervation in the Mouse Brain.

Authors:  Andrea Forero; Olga Rivero; Sina Wäldchen; Hsing-Ping Ku; Dominik P Kiser; Yvonne Gärtner; Laura S Pennington; Jonas Waider; Patricia Gaspar; Charline Jansch; Frank Edenhofer; Thérèse J Resink; Robert Blum; Markus Sauer; Klaus-Peter Lesch
Journal:  Front Cell Neurosci       Date:  2017-09-26       Impact factor: 5.505

View more
  2 in total

1.  Disturbance of phylogenetic layer-specific adaptation of human brain gene expression in Alzheimer's disease.

Authors:  Natasha Andressa Nogueira Jorge; Uwe Ueberham; Mara Knobloch; Peter F Stadler; Jörg Fallmann; Thomas Arendt
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

Review 2.  Molecular pathways of major depressive disorder converge on the synapse.

Authors:  Gabriel R Fries; Valeria A Saldana; Johannes Finnstein; Theo Rein
Journal:  Mol Psychiatry       Date:  2022-10-06       Impact factor: 13.437

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.